Ginkgo Bioworks Holdings (DNA) EBT (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly EBT of -$76.1 million for Q1 2026, up 8.51% year-on-year from -$70.2 million in Q1 2025, and up 6.46% on a QoQ basis from -$81.4 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of EBT data on file, last reported at -$76.1 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 8.51% year-over-year to -$76.1 million; the trailing twelve-month figure through Mar 2026 stood at -$298.9 million (up 35.71% YoY), and the FY2025 full-year result was -$313.6 million, up 42.72% from the prior year.
- EBT for Q1 2026 stood at -$76.1 million, up from -$81.4 million in the prior quarter.
- Across five years, EBT topped out at -$56.8 million in Q3 2024 and bottomed at -$670.6 million in Q2 2022.
- The 5-year median for EBT is -$173.2 million (2023), against an average of -$232.0 million.
- Peak annual rise in EBT reached 88.3% in 2022, while the deepest fall reached 1121.63% in 2022.
- A 5-year view of EBT shows it stood at -$187.8 million in 2022, then retreated by 12.8% to -$211.9 million in 2023, then jumped by 49.1% to -$107.9 million in 2024, then rose by 24.54% to -$81.4 million in 2025, then advanced by 6.46% to -$76.1 million in 2026.
- The last three EBT figures came in at -$76.1 million (Q1 2026), -$81.4 million (Q4 2025), and -$80.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | -76.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.14 Mn |
| Dec 31, 2025 | -81.39 Mn |
| Sep 30, 2025 | -80.75 Mn |
| Jun 30, 2025 | -60.58 Mn |
| Mar 31, 2025 | -83.22 Mn |
| Dec 31, 2024 | -107.86 Mn |
| Sep 30, 2024 | -56.78 Mn |
| Jun 30, 2024 | -216.99 Mn |
| Mar 31, 2024 | -165.88 Mn |
| Dec 31, 2023 | -211.89 Mn |
| Sep 30, 2023 | -302.91 Mn |
| Jun 30, 2023 | -173.25 Mn |
| Mar 31, 2023 | -204.89 Mn |
| Dec 31, 2022 | -187.85 Mn |
| Sep 30, 2022 | -670.16 Mn |
| Jun 30, 2022 | -670.62 Mn |
| Mar 31, 2022 | -592.78 Mn |
| Dec 31, 2021 | -1.61 Bn |
| Sep 30, 2021 | -102.61 Mn |
| Jun 30, 2021 | -54.90 Mn |
| Mar 31, 2021 | -74.94 Mn |
| Dec 31, 2020 | -46.39 Mn |
| Sep 30, 2020 | -26.12 Mn |